Chicago Equity Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$597K Sell
15,155
-10,585
-41% -$619K 0.06% 389
2019
Q4
$1.53M Buy
25,740
+2,585
+11% +$139K 0.09% 338
2019
Q3
$1.23M Buy
23,155
+4,040
+21% +$207K 0.06% 437
2019
Q2
$977K Sell
19,115
-9,620
-33% -$448K 0.04% 524
2019
Q1
$1.49M Sell
28,735
-17,725
-38% -$859K 0.06% 411
2018
Q4
$1.83M Buy
46,460
+14,575
+46% +$677K 0.07% 355
2018
Q3
$1.64M Buy
+31,885
New +$1.56M 0.05% 424
2017
Q2
Sell
-41,190
Closed -$1.89M 869
2017
Q1
$1.89M Buy
41,190
+620
+2% +$30.8K 0.05% 337
2016
Q4
$2.13M Buy
40,570
+10,480
+35% +$507K 0.06% 320
2016
Q3
$1.34M Buy
+30,090
New +$1.31M 0.04% 379

Other funds holding SYNH

Chicago Equity Partners's SYNH Position: Q1 2020 in Review

Chicago Equity Partners reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 41% in Q1 2020, selling an estimated $619K and leaving 15,155 shares worth $597K. The position accounts for 0.06% of the portfolio, ranked #389.

Chicago Equity Partners first reported a position in SYNH in Q3 2016 and has held it in 10 quarters since. The position peaked at $2.13M in Q4 2016. 260 funds tracked by Wall St. Rank hold SYNH as of Q1 2020.

  • Chicago Equity Partners held 15,155 shares of Syneos Health, Inc. Class A Common Stock worth $597K as of Q1 2020.
  • Chicago Equity Partners sold 10,585 Syneos Health, Inc. Class A Common Stock shares in Q1 2020, an estimated $619K.
  • Syneos Health, Inc. Class A Common Stock made up 0.06% of Chicago Equity Partners's portfolio in Q1 2020, its #389 holding.
  • Chicago Equity Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and has held it in 10 quarters since.
  • Chicago Equity Partners's Syneos Health, Inc. Class A Common Stock position peaked at $2.13M in Q4 2016.
  • 260 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.